Clinical Trial Update: Biological Standardization of Poa Pratensis Allergen Extract [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the biological standardization of Poa pratensis allergen extract for grass pollen allergy. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Grass Pollen Allergy

Drugs mentioned

• Poa pratensis allergen extract (Poa pratensis pollen allergen extract)

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Allergy to Grass Pollen | Phase 2 | Status: COMPLETED